Showing 2,421 - 2,440 results of 4,404 for search '"Clinical trial"', query time: 0.09s Refine Results
  1. 2421
  2. 2422
  3. 2423
  4. 2424

    In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems: Protocol for a Scoping Review by Michael Dorosan, Ya-Lin Chen, Qingyuan Zhuang, Shao Wei Sean Lam

    Published 2025-01-01
    “…Such CDS systems are traditionally assessed via controlled but resource-intensive clinical trials. ObjectiveThis paper presents a review protocol for preimplementation in silico evaluation methods to enable broadened impact analysis under simulated environments before clinical trials. …”
    Get full text
    Article
  5. 2425
  6. 2426
  7. 2427

    Trajectories of Change, Illness Understanding, and Parental Worries in Children and Adolescents Undergoing Internet-Delivered Cognitive-Behavioral Therapy for Functional Abdominal... by Eva Skovslund Nielsen, Karen Kallesøe, Tine Bennedsen Gehrt, Ellen Bjerre-Nielsen, Maria Lalouni, Lisbeth Frostholm, Marianne Bonnert, Charlotte Ulrikka Rask

    Published 2025-01-01
    “…Trial RegistrationClinicalTrials.gov NCT05237882; https://clinicaltrials.gov/study/NCT05237882; ClinicalTrials.gov NCT05486585; https://clinicaltrials.gov/study/NCT05486585; OSF Registries osf.io/c49k7; https://osf.io/c49k7 International Registered Report Identifier (IRRID)DERR1-10.2196/58563…”
    Get full text
    Article
  8. 2428

    CAR T-cell detection scoping review: an essential biomarker in critical need of standardization by Naomi Taylor, Nirali N Shah, David P Turicek, Victoria M Giordani, Josquin Moraly

    Published 2023-05-01
    “…To evaluate whether subsequent manuscripts from a trial resolved these issues, we analyzed all subsequent manuscripts reporting on the 21 clinical trials, recording all expansion and persistence data. …”
    Get full text
    Article
  9. 2429
  10. 2430

    Exact Group Sequential Methods for Estimating a Binomial Proportion by Zhengjia Chen, Xinjia Chen

    Published 2013-01-01
    “…Illustrative examples are given for applications in clinical trials.…”
    Get full text
    Article
  11. 2431

    Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment by Andrzej Kuźmiński, Tomasz Rosada, Justyna Przybyszewska, Natalia Ukleja-Sokołowska, Zbigniew Bartuzi

    Published 2022-08-01
    “…Unfortunately, there is still a lack of well-designed, prospective. and randomized clinical trials involving large groups of patients with EGE and assessing the effectiveness of individual treatments. …”
    Get full text
    Article
  12. 2432

    The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review by Jed W. Fahey, Mirran Raphaely

    Published 2025-01-01
    “…SF has been the subject of thousands of studies and over 125 clinical trials. The many mechanisms of action of SF in mammalian systems have been extensively documented. …”
    Get full text
    Article
  13. 2433

    Control of atropoisomerism: an access to valuable compounds by Choppin, Sabine, Wencel-Delord, Joanna, Colobert, Françoise

    Published 2024-03-01
    “…Atropoisomerism is well-known in biaryls, however this phenomenon is encountered in many pharmaceutically relevant compounds such as heterobiaryl, diarylamines, benzamides and anilides.Currently four FDA-approved drugs are atropostable and many others are in clinical trials. It is also important to note that almost 30% of recent FDA-approved small molecules are “proatropisomeric” and interact with a target in a specific chiral conformation.Given this vivid interest in C–C but also C–N atropisomerically stable compounds, this account will detail the new atropoisomeric strategies we developed and their applications in the synthesis of relevant molecules and ligands.…”
    Get full text
    Article
  14. 2434

    Application of bone turnover markers in skeletal and extra-skeletal conditions in children and adults by Agnieszka Postępska, Przemysław Sikora

    Published 2024-12-01
    “…Therefore, there is a need for standardized clinical trials on currently available and new BTMs.…”
    Get full text
    Article
  15. 2435

    Convergence of evolving artificial intelligence and machine learning techniques in precision oncology by Elena Fountzilas, Tillman Pearce, Mehmet A. Baysal, Abhijit Chakraborty, Apostolia M. Tsimberidou

    Published 2025-01-01
    “…., digital twins, in order to provide the necessary information to design or expedite the conduct of clinical trials. Currently, many operational and technical challenges exist related to data technology, engineering, and storage; algorithm development and structures; quality and quantity of the data and the analytical pipeline; data sharing and generalizability; and the incorporation of these technologies into the current clinical workflow and reimbursement models.…”
    Get full text
    Article
  16. 2436

    Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions by Wang-Soo Lee, Jaetaek Kim

    Published 2015-01-01
    “…We also describe the results and lessons learned from important clinical trials on PPAR agonists and discuss the potential future directions for this class of drugs.…”
    Get full text
    Article
  17. 2437

    Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup by Maribel Fernández, María Gil, Francisco Gomez-Ulla, Pablo Charlón

    Published 2012-01-01
    “…These data need to be confirmed in large, prospective, and controlled clinical trials which are randomized and carried out over a long period.…”
    Get full text
    Article
  18. 2438

    PPARγ and Its Role in Cardiovascular Diseases by Mini Chandra, Sumitra Miriyala, Manikandan Panchatcharam

    Published 2017-01-01
    “…This review aims to discuss the role of PPARγ in the various cardiovascular diseases and summarize the current knowledge on PPARγ agonists from multiple clinical trials. Finally, we also review the new PPARγ agonists under development as potential therapeutics with reduced or no adverse effects.…”
    Get full text
    Article
  19. 2439

    Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? by Patrice Carter, Kamlesh Khunti, Melanie J. Davies

    Published 2012-01-01
    “…In addition we aim to explore the available evidence from both observation studies and clinical trials to determine whether these recommendations are appropriate.…”
    Get full text
    Article
  20. 2440

    Receptor Tyrosine Kinases and Inhibitors in Lung Cancer by Evan Pisick, Simha Jagadeesh, Ravi Salgia

    Published 2004-01-01
    “…The inhibitors against the specific RTKs are in various preclinical and clinical trials, and this will be detailed.…”
    Get full text
    Article